Advertisement

Topics

They’re Children Are Dying. So These Families Are Racing to Raise Money for Research No One Else Will Fund

11:54 EDT 3 Jul 2017 | Bioethics.com

(STAT News) – Rare diseases are increasingly attractive to biopharma companies, which can charge premium prices if they come up with a therapy. (One drug that just hit the market is priced at $750,000 for the first year of treatment.) But … Read More

Original Article: They’re Children Are Dying. So These Families Are Racing to Raise Money for Research No One Else Will Fund

NEXT ARTICLE

More From BioPortfolio on "They’re Children Are Dying. So These Families Are Racing to Raise Money for Research No One Else Will Fund"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...